Last reviewed · How we verify

NCT05529888

Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin.

Completed Phase 4 Last updated 7 September 2022
What this trial tests

Phase 4 trial testing Isotretinoin in Acne Vulgaris in 60 participants. Completed in 15 December 2021.

Timeline
15 December 2020
Primary endpoint
15 December 2021
15 December 2021

Quick facts

Lead sponsorAswan University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposediagnostic
Enrollment60
Start date15 December 2020
Primary completion15 December 2021
Estimated completion15 December 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aswan University

Who can join

Adults 15 to 45, any sex, with Acne Vulgaris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Serum homocysteine level in Acne patients before and after oral Isotretinoin and Correlation between serum level of homocysteine in acne patients before and after Oral isotretinoin treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Isotretinoin

Trials testing the same drug.

Other recruiting trials for Acne Vulgaris

Currently open trials in the same condition.

Other Aswan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05529888.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing